Comments on article by Tran and associates, "Double-blind comparison of olanzapine versus risperidone in treatment of schizophrenia and other psychotic disorders" - Reply - Letter to the editor

被引：10
|
作者：
Tollefson, GD [1 ]
Tran, PV [1 ]
机构：
[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Clin Res, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1998年 / 18卷 / 02期
关键词：
D O I：
10.1097/00004714-199804000-00016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：177 / 179
页数：3
相关论文
共 50 条
  • [41] A Randomized, Double-Blind Comparison of Risperidone Versus Low-Dose Risperidone Plus Low-Dose Haloperidol in Treating Schizophrenia
    Lin, Ching-Hua
    Kuo, Chao-Chan
    Chou, Li-Shiu
    Chen, Yeng-Hung
    Chen, Cheng-Chung
    Huang, Kuo-Hao
    Lane, Hsien-Yuan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (05) : 518 - 525
  • [42] Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents
    Glick, ID
    Lemmens, P
    Vester-Blokland, E
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (05) : 265 - 274
  • [43] Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison
    McEvoy, Joseph P.
    Lieberman, Jeffrey A.
    Perkins, Diana O.
    Hamer, Robert M.
    Gu, Hongbin
    Lazarus, Arthur
    Sweitzer, Dennis
    Olexy, Christina
    Weiden, Peter
    Strakowski, Stephen D.
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (07): : 1050 - 1060
  • [44] Intramuscular olanzapine versus intramuscular aripiprazole for the treatment of agitation in patients with schizophrenia: A pragmatic double-blind randomized trial
    Kittipeerachon, Mantana
    Chaichan, Warawat
    SCHIZOPHRENIA RESEARCH, 2016, 176 (2-3) : 231 - 238
  • [45] Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: A double-blind randomized controlled trial
    van Nimwegen, Lonneke J.
    de Haan, Lieuwe
    van Beveren, Nico J. M.
    van der Helm, Mischa
    van den Brink, Wim
    Linszen, Don
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2008, 53 (06): : 400 - 405
  • [46] Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia
    Wright, P
    Birkett, M
    David, SR
    Meehan, K
    Ferchland, I
    Alaka, KJ
    Saunders, JC
    Krueger, J
    Bradley, P
    San, L
    Bernardo, M
    Reinstein, M
    Breier, A
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (07): : 1149 - 1151
  • [47] A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia
    Meltzer, Herbert Y.
    Bobo, William V.
    Roy, Ajanta
    Jayathilake, Karu
    Chen, Yuejin
    Ertugrul, Aygun
    Yagcioglu, A. Elif Anil
    Small, Joyce G.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (02) : 274 - 285
  • [48] Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial
    Sakurai, Hitoshi
    Suzuki, Takefumi
    Bies, Robert R.
    Pollock, Bruce G.
    Mimura, Masaru
    Kapur, Shitij
    Uchida, Hiroyuki
    JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (10) : 1381 - +
  • [49] A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia
    Tollefson, GD
    Sanger, TM
    Beasley, CM
    Tran, PV
    BIOLOGICAL PSYCHIATRY, 1998, 43 (11) : 803 - 810
  • [50] Escitalopram versus risperidone for the treatment of behavioral and psychotic symptoms associated with Alzheimer's disease: a randomized double-blind pilot study
    Barak, Yoram
    Plopski, Igor
    Tadger, Shelly
    Paleacu, Diana
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 (09) : 1515 - 1519
12345